STOCK TITAN

Form 4: Wineinger Matthew David reports acquisition/exercise transactions in BCPC

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Wineinger Matthew David reported acquisition or exercise transactions in a Form 4 filing for BCPC. The filing lists transactions totaling 870 shares. Following the reported transactions, holdings were 8,012 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wineinger Matthew David

(Last) (First) (Middle)
C/O BALCHEM CORPORATION
5 PARAGON DRIVE

(Street)
MONTVALE NJ 07645

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/11/2026 A 870(1) A $0 8,012 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
/s/ Travis Larsen, Attorney in Fact for Matthew David Wineinger 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BCPC director Matthew David Wineinger report?

Matthew David Wineinger reported receiving 870 shares of BCPC common stock as an equity grant. The grant was priced at $0 per share and increased his direct beneficial ownership to 8,012 shares, reflecting stock-based compensation rather than a market purchase or sale.

When did Matthew David Wineinger receive the 870-share BCPC stock grant?

Wineinger received the 870-share BCPC common stock grant on February 11, 2026. This date is the formal grant and transaction date, which also starts the one-year vesting clock for the restricted stock under the applicable Restricted Stock Grant Agreement.

Is the 870-share BCPC stock grant to Matthew David Wineinger immediately vested?

No, the 870 BCPC shares are granted as restricted stock that vests after one year. Until vesting, the shares are subject to transfer restrictions outlined in the Restricted Stock Grant Agreement between the company and Wineinger, limiting his ability to sell or transfer them.

How many BCPC shares does Matthew David Wineinger own after this transaction?

After the grant, Wineinger beneficially owns 8,012 BCPC common shares directly. This figure includes the newly awarded 870 restricted shares, which will vest one year after the February 11, 2026 grant date, assuming all vesting conditions in the agreement are satisfied.

Was cash paid for the 870 BCPC shares granted to Matthew David Wineinger?

No cash was paid; the 870 BCPC shares were granted at a price of $0 per share. This indicates the transaction is a stock-based compensation award, not an open-market purchase, and is governed by terms in the Restricted Stock Grant Agreement.
Balchem Corp

NASDAQ:BCPC

View BCPC Stock Overview

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.26B
31.82M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE